A dual deprescribing intervention for proton pump inhibitors (PPIs) targeting patients and their primary care doctors proved ...
CSIS Americas Fellow Diego Marroquin Bitar analyzes the current North American digital trade framework ahead of the 2026 ...
Penumbra (NYSE:PEN) today announced 90-day results from the landmark STORM-PE randomized trial of its thrombectomy technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results